Cleerly Unveils Groundbreaking Late-Breaking Clinical Trial Results Demonstrating AI-QCT’s Predictive Power for Women’s Cardiovascular Risk at ACC.25 New Findings from the CONFIRM2 Registry Reveal Significant Gender Disparities in Coronary Plaque Features and...
CuraSen Therapeutics Announces First Subject Treated with CuraAX (CST-3056) in a Phase 1 Clinical Trial CuraAX Designed to Treat Neurogenic Orthostatic Hypotension (nOH) and Cognitive Impairment San Carlos, CA – February 20, 2025 – CuraSen Therapeutics, Inc., a...
Kyruus Health Achieves Record Growth as Searches for Care Surpass 1 Billion Care access leader adds 12M health plan members and 100 new provider organizations to its platform BOSTON, MA – FEB. 5, 2024 – Kyruus Health delivered record-breaking growth in 2024,...
Rallybio Announces Initiation of Dosing in RLYB212 Phase 2 Clinical Trial – Key Data Readouts from Sentinel Participant Expected in 2Q 2025 and 3Q 2025 – NEW HAVEN, Conn.–(BUSINESS WIRE)–Feb. 11, 2025– Rallybio Corporation (Nasdaq: RLYB), a...
Kyruus Health and aha! Announce Partnership to Enhance Patient Access and Engagement UCI Health Leads the Way in Patient-Centric Digital Experiences with Kyruus Health and aha! Partnership BOSTON, MA – FEB. 13, 2024 – Kyruus Health, the leading care access platform,...
Bluesight Expands Compliance Capabilities and Strengthens Platform through Acquisition of Protenus ALEXANDRIA and BALTIMORE, January 9, 2025 – Bluesight, the leading provider of inventory management, procurement, and compliance solutions for health systems and...
Recent Comments